T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy

Francesco Dieli, Filippo Brighina, Guido Sireci, Giuliana Guggino, Giovanni Triolo, Diana Di Liberto, Stefania Raimondo, Riccardo Alessandro, Marianna Lo Pizzo, Piercarlo Sarzi-Puttini, Piero Ruscitti, Domenico Garbo, Roberto Giacomelli, Roberto Casale, Claudia Schinocca, Domenico Garbo

Risultato della ricerca: Article

1 Citazioni (Scopus)


Hyperbaric oxygen therapy (HBOT) has been used as treatment for different clinical conditions, including fibromyalgia (FM). HBOT modulates brain activity, ameliorates chronic pain and modifies the ratio of immune cells. Clinical studies have provided evidence that FM is associated with immune system dysregulation. In the present study we aimed to evaluate the effect of HBOT on immune system and on the quality of life-style of FM patients.
Lingua originaleEnglish
pagine (da-a)81-89
Numero di pagine9
RivistaClinical and Experimental Rheumatology
Volume37 Suppl 116
Stato di pubblicazionePublished - 2019


All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cita questo